Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen, Inc. | 2.32% | 289.18 | 1.4% | $863.03m | |
| CELG | Celgene Corp. | -1.02% | 108.20 | 1.3% | $561.40m | |
| AMGN | Amgen, Inc. | 1.00% | 222.88 | 1.3% | $532.69m | |
| GILD | Gilead Sciences, Inc. | 0.93% | 64.89 | 1.0% | $395.88m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.11% | 214.42 | 1.9% | $329.41m | |
| ILMN | Illumina, Inc. | 1.26% | 310.52 | 3.5% | $328.11m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.75% | 342.75 | 2.6% | $272.61m | |
| EXAS | EXACT Sciences Corp. | 3.48% | 85.02 | 24.0% | $225.98m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.20% | 110.34 | 2.0% | $183.35m | |
| SGEN | Seattle Genetics, Inc. | 0.82% | 116.68 | 6.1% | $142.03m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.58% | 76.36 | 4.3% | $128.89m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.15% | 98.05 | 14.6% | $118.74m | |
| A | Agilent Technologies, Inc. | 1.49% | 79.10 | 1.6% | $99.52m | |
| BGNE | BeiGene Ltd. | 2.45% | 200.82 | 2.1% | $92.59m | |
| NBIX | Neurocrine Biosciences, Inc. | -0.62% | 113.93 | 5.0% | $87.59m |
Company Profile
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Its clinical stage programs are DKN-01 and TRX518. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.